Advertisement
No access
Report

High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR

Science
19 Mar 1993
Vol 259, Issue 5102
pp. 1749-1754

Abstract

Quantitative competitive polymerase chain reaction (QC-PCR) methods were used to quantify virion-associated human immunodeficiency virus type-1 (HIV-1) RNA in plasma from 66 patients with Centers for Disease Control stage I to IVC1 infection. HIV-1 RNA, ranging from 100 to nearly 22,000,000 copies per milliliter of plasma (corresponding to 50 to 11,000,000 virions per milliliter), was readily quantified in all subjects, was significantly associated with disease stage and CD4+ T cell counts, and decreased by as much as 235-fold with resolution of primary infection or institution of antiretroviral therapy. Plasma virus levels determined by QC-PCR correlated with, but exceeded by an average of 60,000-fold, virus titers measured by endpoint dilution culture. Quantitation of HIV-1 in plasma by QC-PCR may be useful in assessing the efficacy of antiretroviral agents, especially in early stage disease when conventional viral markers are often negative.

Get full access to this article

View all available purchase options and get full access to this article.

References

MORBIDITY AND MORTALITY WEEKLY REPORT 35: 334 (1986).
AMADORI, A, IGG OLIGOCLONAL BANDS IN SERA OF HIV-1 INFECTED PATIENTS ARE MAINLY DIRECTED AGAINST HIV-1 DETERMINANTS, AIDS RESEARCH AND HUMAN RETROVIRUSES 6: 581 (1990).
AMEISEN, J.C., CELL DYSFUNCTION AND DEPLETION IN AIDS - THE PROGRAMMED CELL-DEATH HYPOTHESIS, IMMUNOLOGY TODAY 12: 102 (1991).
ANDERSON, R.M., THE ROLE OF MATHEMATICAL-MODELS IN THE STUDY OF HIV TRANSMISSION AND THE EPIDEMIOLOGY OF AIDS, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1: 241 (1988).
AOKISEI, S, PLASMA HIV-1 VIREMIA IN HIV-1 INFECTED INDIVIDUALS ASSESSED BY POLYMERASE CHAIN-REACTION, AIDS RESEARCH AND HUMAN RETROVIRUSES 8: 1263 (1992).
ARTHUR, L.O., CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES, SCIENCE 258: 1935 (1992).
AZIZ, D.C., SEVERE IMMUNODEFICIENCY DISEASE INDUCED BY A DEFECTIVE MURINE LEUKEMIA-VIRUS, NATURE 338: 505 (1989).
BACCHETTI, P, INCUBATION PERIOD OF AIDS IN SAN-FRANCISCO, NATURE 338: 251 (1989).
BAGNARELLI, P, MOLECULAR PROFILE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SYMPTOMLESS PATIENTS AND IN PATIENTS WITH AIDS, JOURNAL OF VIROLOGY 66: 7328 (1992).
BARRESINOUSSI, F, ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS), SCIENCE 220: 868 (1983).
BECKERANDRE, M, ABSOLUTE MESSENGER-RNA QUANTIFICATION USING THE POLYMERASE CHAIN-REACTION (PCR) - A NOVEL-APPROACH BY A PCR AIDED TRANSCRIPT TITRATION ASSAY (PATTY), NUCLEIC ACIDS RESEARCH 17: 9437 (1989).
BOURINBAIAR, A.S., HIV AND GAG, NATURE 349: 111 (1991).
CHATTOPADHYAY, S.K., DEFECTIVE VIRUS IS ASSOCIATED WITH INDUCTION OF MURINE RETROVIRUS-INDUCED IMMUNODEFICIENCY SYNDROME, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 3862 (1989).
CLARK, S.J., HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION, NEW ENGLAND JOURNAL OF MEDICINE 324: 954 (1991).
CLERICI, M, EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC T-HELPER CELL RESPONSES BEFORE DETECTION OF INFECTION BY POLYMERASE CHAIN-REACTION AND SERUM ANTIBODIES, JOURNAL OF INFECTIOUS DISEASES 164: 178 (1991).
CLERICI, M, CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1, JOURNAL OF INFECTIOUS DISEASES 165: 1012 (1992).
COHEN, J, SEARCHING FOR MARKERS ON THE AIDS TRAIL, SCIENCE 258: 388 (1992).
COOMBS, R.W., PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION, NEW ENGLAND JOURNAL OF MEDICINE 321: 1626 (1989).
DAAR, E.S., TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, NEW ENGLAND JOURNAL OF MEDICINE 324: 961 (1991).
DICKOVER, R.E., QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS DNA BY USING THE POLYMERASE CHAIN-REACTION, JOURNAL OF CLINICAL MICROBIOLOGY 28: 2130 (1990).
FAUCI, A.S., IMMUNOPATHOGENIC MECHANISMS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, ANNALS OF INTERNAL MEDICINE 114: 678 (1991).
FAUCI, A.S., THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS, SCIENCE 239: 617 (1988).
GILLILAND, G, ANALYSIS OF CYTOKINE MESSENGER-RNA AND DNA - DETECTION AND QUANTITATION BY COMPETITIVE POLYMERASE CHAIN-REACTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 2725 (1990).
Gilliland, G., PCR Protocols: A Guide to Methods and Applications: 60 (1990).
GRAZIOSI, C, CLIN RES 40: 333 (1992).
GROUX, H, ACTIVATION-INDUCED DEATH BY APOPTOSIS IN CD4+ T-CELLS FROM HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED ASYMPTOMATIC INDIVIDUALS, JOURNAL OF EXPERIMENTAL MEDICINE 175: 331 (1992).
HO, D.D., QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS, NEW ENGLAND JOURNAL OF MEDICINE 321: 1621 (1989).
HOLODNIY, M, DETECTION AND QUANTIFICATION OF GENE AMPLIFICATION PRODUCTS BY A NONISOTOPIC AUTOMATED-SYSTEM, BIOTECHNIQUES 12: 36 (1992).
HOLODNIY, M, REDUCTION IN PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID AFTER DIDEOXYNUCLEOSIDE THERAPY AS DETERMINED BY THE POLYMERASE CHAIN-REACTION, JOURNAL OF CLINICAL INVESTIGATION 88: 1755 (1991).
IMBERTI, L, SELECTIVE DEPLETION IN HIV-INFECTION OF T-CELLS THAT BEAR SPECIFIC T-CELL RECEPTOR-V-BETA SEQUENCES, SCIENCE 254: 860 (1991).
JURRIAANS, S, HIV-1 VIRAL-DNA LOAD IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM SEROCONVERTERS AND LONG-TERM INFECTED INDIVIDUALS, AIDS 6: 635 (1992).
LANE, H.C., QUALITATIVE-ANALYSIS OF IMMUNE FUNCTION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME - EVIDENCE FOR A SELECTIVE DEFECT IN SOLUBLE-ANTIGEN RECOGNITION, NEW ENGLAND JOURNAL OF MEDICINE 313: 79 (1985).
LAURENTCRAWFORD, A.G., THE CYTOPATHIC EFFECT OF HIV IS ASSOCIATED WITH APOPTOSIS, VIROLOGY 185: 829 (1991).
LAYNE, S.P., FACTORS UNDERLYING SPONTANEOUS INACTIVATION AND SUSCEPTIBILITY TO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, VIROLOGY 189: 695 (1992).
LEVY, J.A., ISOLATION OF LYMPHOCYTOPATHIC RETROVIRUSES FROM SAN-FRANCISCO PATIENTS WITH AIDS, SCIENCE 225: 840 (1984).
LI, Y.X., MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONED DIRECTLY FROM UNCULTURED HUMAN BRAIN-TISSUE - IDENTIFICATION OF REPLICATION-COMPETENT AND REPLICATION-DEFECTIVE VIRAL GENOMES, JOURNAL OF VIROLOGY 65: 3973 (1991).
LI, Y.X., COMPLETE NUCLEOTIDE-SEQUENCE, GENOME ORGANIZATION, AND BIOLOGICAL PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO - EVIDENCE FOR LIMITED DEFECTIVENESS AND COMPLEMENTATION, JOURNAL OF VIROLOGY 66: 6587 (1992).
LINETTE, G.P., HIV-1 INFECTED T-CELLS SHOW A SELECTIVE SIGNALING DEFECT AFTER PERTURBATION OF CD3/ANTIGEN RECEPTOR, SCIENCE 241: 573 (1988).
MANN, D.L., HTLV-III LARGE ENVELOPE PROTEIN (GP120) SUPPRESSES PHA-INDUCED LYMPHOCYTE BLASTOGENESIS, JOURNAL OF IMMUNOLOGY 138: 2640 (1987).
MARGOLICK, J.B., AMPLIFICATION OF HTLV-III/LAV INFECTION BY ANTIGEN-INDUCED ACTIVATION OF T-CELLS AND DIRECT SUPPRESSION BY VIRUS OF LYMPHOCYTE BLASTOGENIC RESPONSES, JOURNAL OF IMMUNOLOGY 138: 1719 (1987).
MCKEATING, J.A., HIV INFECTIVITY, NATURE 349: 660 (1991).
MENZO, S, ABSOLUTE QUANTITATION OF VIREMIA IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY COMPETITIVE REVERSE TRANSCRIPTION AND POLYMERASE CHAIN-REACTION, JOURNAL OF CLINICAL MICROBIOLOGY 30: 1752 (1992).
MEYAARD, L, PROGRAMMED DEATH OF T-CELLS IN HIV-1 INFECTION, SCIENCE 257: 217 (1992).
MEYERHANS, A, TEMPORAL FLUCTUATIONS IN HIV QUASISPECIES INVIVO ARE NOT REFLECTED BY SEQUENTIAL HIV ISOLATIONS, CELL 58: 901 (1989).
MICHAEL, N.L., VIRAL-DNA AND MESSENGER-RNA EXPRESSION CORRELATE WITH THE STAGE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INFECTION IN HUMANS - EVIDENCE FOR VIRAL REPLICATION IN ALL STAGES OF HIV DISEASE, JOURNAL OF VIROLOGY 66: 310 (1992).
MITTLER, R.S., SYNERGISM BETWEEN HIV-GP120 AND GP120-SPECIFIC ANTIBODY IN BLOCKING HUMAN T-CELL ACTIVATION, SCIENCE 245: 1380 (1989).
MOORE, J.P., DISSOCIATION OF GP120 FROM HIV-1 VIRIONS INDUCED BY SOLUBLE CD4, SCIENCE 250: 1139 (1990).
MUNOZ, A, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)-FREE TIME AFTER HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) SEROCONVERSION IN HOMOSEXUAL MEN, AMERICAN JOURNAL OF EPIDEMIOLOGY 130: 530 (1989).
MURAKAWA, G.J., DNA CELL BIOL 239: 295 (1988).
Myers, G., Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (1991).
NARA, P.L., NEUTRALIZATION OF HIV-1 - A PARADOX OF HUMORAL PROPORTIONS, FASEB JOURNAL 5: 2437 (1991).
NEWELL, M.K., DEATH OF MATURE T-CELLS BY SEPARATE LIGATION OF CD4 AND THE T-CELL RECEPTOR FOR ANTIGEN, NATURE 347: 286 (1990).
NOONAN, K.E., QUANTITATIVE-ANALYSIS OF MDR1 (MULTIDRUG RESISTANCE) GENE-EXPRESSION IN HUMAN TUMORS BY POLYMERASE CHAIN-REACTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 7160 (1990).
OTTMANN, M, THE POLYMERASE CHAIN-REACTION FOR THE DETECTION OF HIV-1 GENOMIC RNA IN PLASMA FROM INFECTED INDIVIDUALS, JOURNAL OF VIROLOGICAL METHODS 31: 273 (1991).
OVERBAUGH, J, MOLECULAR-CLONING OF A FELINE LEUKEMIA-VIRUS THAT INDUCES FATAL IMMUNODEFICIENCY DISEASE IN CATS, SCIENCE 239: 906 (1988).
PANTALEO, G, THE IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, NEW ENGLAND JOURNAL OF MEDICINE 328: 327 (1993).
PANTALEO, G, LYMPHOID ORGANS FUNCTION AS MAJOR RESERVOIRS FOR HUMAN-IMMUNODEFICIENCY-VIRUS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 9838 (1991).
PIATAK, M, QUANTITATIVE COMPETITIVE POLYMERASE CHAIN-REACTION FOR ACCURATE QUANTITATION OF HIV DNA AND RNA SPECIES, BIOTECHNIQUES 14: 70 (1993).
PIATAK, M, unpublished data.
POPOVIC, M, DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS, SCIENCE 224: 497 (1984).
ROBERTGUROFF, M, HTLV-III-NEUTRALIZING ANTIBODIES IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX, NATURE 316: 72 (1985).
SAAG, M.S., HIGH-LEVEL VIREMIA IN ADULTS AND CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - RELATION TO DISEASE STAGE AND CD4+ LYMPHOCYTE LEVELS, JOURNAL OF INFECTIOUS DISEASES 164: 72 (1991).
SCADDEN, D.T., QUANTITATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA BY COMPETITIVE POLYMERASE CHAIN-REACTION, JOURNAL OF INFECTIOUS DISEASES 165: 1119 (1992).
SCHNITTMAN, S.M., FREQUENT DETECTION OF HIV-1-SPECIFIC MESSENGER-RNAS IN INFECTED INDIVIDUALS SUGGESTS ONGOING ACTIVE VIRAL EXPRESSION IN ALL STAGES OF DISEASE, AIDS RESEARCH AND HUMAN RETROVIRUSES 7: 361 (1991).
SHALABY, M.R., THE EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS RECOMBINANT ENVELOPE GLYCOPROTEIN ON IMMUNE CELL FUNCTIONS INVITRO, CELLULAR IMMUNOLOGY 110: 140 (1987).
STEIN, D.S., CD4+ LYMPHOCYTE CELL ENUMERATION FOR PREDICTION OF CLINICAL COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - A REVIEW, JOURNAL OF INFECTIOUS DISEASES 165: 352 (1992).
STIEGER, M, COMPETITIVE POLYMERASE CHAIN-REACTION ASSAY FOR QUANTITATION OF HIV-1 DNA AND RNA, JOURNAL OF VIROLOGICAL METHODS 34: 149 (1991).
TERAI, C, APOPTOSIS AS A MECHANISM OF CELL-DEATH IN CULTURED T-LYMPHOBLASTS ACUTELY INFECTED WITH HIV-1, JOURNAL OF CLINICAL INVESTIGATION 87: 1710 (1991).
TERSMETTE, M, EVIDENCE FOR A ROLE OF VIRULENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) VARIANTS IN THE PATHOGENESIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME - STUDIES ON SEQUENTIAL HIV ISOLATES, JOURNAL OF VIROLOGY 63: 2118 (1989).
TERSMETTE, M, ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY, LANCET 1: 983 (1989).
WEISS, R.A., NEUTRALIZATION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III BY SERA OF AIDS AND AIDS-RISK PATIENTS, NATURE 316: 69 (1985).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 259 | Issue 5102
19 March 1993

Submission history

Published in print: 19 March 1993

Permissions

Request permissions for this article.

Authors

Affiliations

M. Piatak, Jr.
Division of HIV and Exploratory Research, Genelabs Technologies Inc., Redwood City, CA 94063.
M. S. Saag
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.
L. C. Yang
Division of HIV and Exploratory Research, Genelabs Technologies Inc., Redwood City, CA 94063.
S. J. Clark
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.
J. C. Kappes
Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
K.-C. Luk
Division of HIV and Exploratory Research, Genelabs Technologies Inc., Redwood City, CA 94063.
B. H. Hahn
Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
G. M. Shaw
Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
J. D. Lifson
Division of HIV and Exploratory Research, Genelabs Technologies Inc., Redwood City, CA 94063.

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Cell Cycle Arrest by Vpr in HIV-1 Virions and Insensitivity to Antiretroviral Agents, Science, 281, 5374, (266-269), (1998)./doi/10.1126/science.281.5374.266
    Abstract
  2. Viral Counts Count in HIV Infection, Science, 272, 5265, (1124-1125), (1996)./doi/10.1126/science.272.5265.1124
    Abstract
  3. Plasma Viral Load, CD4+ Cell Counts, and HIV-1 Production by Cells, Science, 271, 5249, (670-671), (1996)./doi/10.1126/science.271.5249.670
    Abstract
  4. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response, Science, 271, 5248, (497-499), (1996)./doi/10.1126/science.271.5248.497
    Abstract
  5. HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy, Science, 267, 5197, (483-489), (1995)./doi/10.1126/science.7824947
    Abstract
  6. Scientific and Social Issues of Human Immunodeficiency Virus Vaccine Development, Science, 260, 5112, (1279-1286), (1993)./doi/10.1126/science.8493572
    Abstract
  7. How Does HIV Cause AIDS?, Science, 260, 5112, (1273-1279), (1993)./doi/10.1126/science.8493571
    Abstract
  8. Keystone's Blunt Message: 'It's The Virus, Stupid', Science, 260, 5106, (292-293), (1993)./doi/10.1126/science.8469983
    Abstract
  9. Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection, Science, 261, 5125, (1179-1181), (1993)./doi/10.1126/science.8356453
    Abstract
  10. Effect of Platelet-Associated Virus on Assays of HIV-1 in Plasma, Science, 262, 5139, (1585-1585), (1993)./doi/10.1126/science.8248811
    Abstract
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media